View ValuationWuhu Token Sciences 将来の成長Future 基準チェック /06現在、 Wuhu Token Sciencesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Electronic 収益成長33.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • Jul 25New major risk - Revenue and earnings growthEarnings have declined by 30% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 30% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.5% net profit margin).お知らせ • Jun 30Wuhu Token Sciences Co., Ltd. to Report First Half, 2026 Results on Aug 28, 2026Wuhu Token Sciences Co., Ltd. announced that they will report first half, 2026 results on Aug 28, 2026Declared Dividend • May 30Dividend reduced to CN¥0.05Dividend of CN¥0.05 is 15% lower than last year. Ex-date: 3rd June 2026 Payment date: 3rd June 2026 Dividend yield will be 0.7%, which is lower than the industry average of 1.8%. Sustainability & Growth Dividend is covered by earnings (74% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 66% over the next year, which should provide support to the dividend and adequate earnings cover.お知らせ • May 30Wuhu Token Sciences Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 3 June 2026Wuhu Token Sciences Co., Ltd. announced 2025 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included) of CNY 0.50000000. Record date: 02 June 2026, Ex-date: 03 June 2026, Payment date: 03 June 2026.お知らせ • Apr 27Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 18, 2026Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Wuhu, Anhui Chinaお知らせ • Mar 31Wuhu Token Sciences Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026Wuhu Token Sciences Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026お知らせ • Dec 31Wuhu Token Sciences Co., Ltd. to Report Fiscal Year 2025 Results on Apr 27, 2026Wuhu Token Sciences Co., Ltd. announced that they will report fiscal year 2025 results on Apr 27, 2026お知らせ • Sep 30Wuhu Token Sciences Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Wuhu Token Sciences Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025お知らせ • Jul 02Wuhu Token Sciences Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025Wuhu Token Sciences Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025お知らせ • Apr 25Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 15, 2025Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 15, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Wuhu, Anhui Chinaお知らせ • Mar 31Wuhu Token Sciences Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025Wuhu Token Sciences Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025お知らせ • Dec 31Wuhu Token Sciences Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025Wuhu Token Sciences Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: CN¥0.044 (vs CN¥0.035 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.044 (up from CN¥0.035 in 3Q 2023). Revenue: CN¥3.02b (up 3.3% from 3Q 2023). Net income: CN¥108.4m (up 26% from 3Q 2023). Profit margin: 3.6% (up from 2.9% in 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 33%After last week's 33% share price gain to CN¥6.20, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 21x in the Electronic industry in China. Total loss to shareholders of 13% over the past three years.お知らせ • Sep 30Wuhu Token Sciences Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024Wuhu Token Sciences Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024Valuation Update With 7 Day Price Move • Sep 04Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥5.45, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Electronic industry in China. Total loss to shareholders of 30% over the past three years.Reported Earnings • Aug 29Second quarter 2024 earnings released: EPS: CN¥0.055 (vs CN¥0.047 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.055 (up from CN¥0.047 in 2Q 2023). Revenue: CN¥3.02b (up 59% from 2Q 2023). Net income: CN¥135.1m (up 17% from 2Q 2023). Profit margin: 4.5% (down from 6.1% in 2Q 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.お知らせ • Jun 29Wuhu Token Sciences Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024Wuhu Token Sciences Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024Declared Dividend • Jun 03Dividend reduced to CN¥0.07Dividend of CN¥0.07 is 30% lower than last year. Ex-date: 7th June 2024 Payment date: 7th June 2024 Dividend yield will be 1.4%, which is lower than the industry average of 1.8%. Sustainability & Growth Dividend is not adequately covered by earnings (90.5% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share is expected to grow by 213% over the next 3 years, which should maintain adequate earnings cover for the dividend.お知らせ • Jun 01Wuhu Token Sciences Co., Ltd. Implements 2023 Final Profit Distribution Plan of A Shares, Payable on 07 June 2024Wuhu Token Sciences Co., Ltd. announced 2023 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 0.70000000. Record date: 06 June 2024, Ex-date: 07 June 2024, Payment date: 07 June 2024.お知らせ • Apr 28Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 17, 2024Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 17, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Wuhu, Anhui China Agenda: To consider 2023 work report of the board of directors; to consider 2023 annual accounts report; to consider 2023 annual report and its summary; to consider 2023 profit distribution plan; to consider Reappointment of audit firm; to consider 2023 internal control self-evaluation report; to consider 2024 guarantee for subsidiaries and joint stock companies; to consider 2024 provision of guarantee for a company; to consider Special report on the deposit and use of raised funds in 2023; to consider Change of the Company's registered capital and amendments to the Company's articles of association; to consider 2023 work report of the supervisory committee; to consider Amendments to the work system for independent directors; and to consider Formulation of the allowance management measures for independent directors.お知らせ • Apr 27Wuhu Token Sciences Co., Ltd. Proposes Final Cash Dividend for the Year 2023Wuhu Token Sciences Co., Ltd. proposed final cash dividend per 10 shares (tax included) of CNY 0.70000000 for the year 2023.Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.043 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.02 (down from CN¥0.043 in 1Q 2023). Revenue: CN¥2.60b (up 77% from 1Q 2023). Net income: CN¥49.5m (down 53% from 1Q 2023). Profit margin: 1.9% (down from 7.1% in 1Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.New Risk • Apr 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.0% net profit margin).お知らせ • Mar 30Wuhu Token Sciences Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Wuhu Token Sciences Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥4.61, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Electronic industry in China. Total loss to shareholders of 38% over the past three years.お知らせ • Dec 30Wuhu Token Sciences Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Wuhu Token Sciences Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥7.85, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 22x in the Electronic industry in China. Total loss to shareholders of 21% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥3.73 per share.Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.035 (vs CN¥0.089 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.035 (down from CN¥0.089 in 3Q 2022). Revenue: CN¥2.92b (up 49% from 3Q 2022). Net income: CN¥85.9m (down 61% from 3Q 2022). Profit margin: 2.9% (down from 11% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Wuhu Token Sciences Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023Wuhu Token Sciences Co., Ltd. announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023お知らせ • Sep 14Wuhu Token Sciences Co., Ltd. Announces Executive ElectionsWuhu Token Sciences Co., Ltd. elected Jiang Mingyin and Wu Yunfei as non-independent directors; Luo Kun and Qian Jun as independent directors; and Chang Liping and Wang Wei as non-employee supervisors at the extraordinary general meeting held on September 11, 2023.New Risk • Sep 03New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 24% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.5% net profit margin).Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.047 (vs CN¥0.075 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.047 (down from CN¥0.075 in 2Q 2022). Revenue: CN¥1.90b (up 27% from 2Q 2022). Net income: CN¥115.5m (down 37% from 2Q 2022). Profit margin: 6.1% (down from 12% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has fallen by 23% per year, which means it is performing significantly worse than earnings.お知らせ • May 27Wuhu Token Sciences Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 2, 2023Wuhu Token Sciences Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 0.99999900 on A shares for the year 2022. Record date is June 1, 2023. Ex-date is June 2, 2023. Payment date is June 2, 2023.Reported Earnings • Apr 15Full year 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.37 in FY 2021)Full year 2022 results: EPS: CN¥0.28 (down from CN¥0.37 in FY 2021). Revenue: CN¥6.99b (flat on FY 2021). Net income: CN¥679.7m (down 25% from FY 2021). Profit margin: 9.7% (down from 13% in FY 2021). Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 9% per year.お知らせ • Feb 15Wuhu Token Sciences Co., Ltd. (SZSE:300088) agreed to acquire remaining 43.86% stake in Hybio Pharmaceutical Co., Ltd. (SZSE : 300199) from Anhui Province Railway Development Fund Co.,Ltd. and Wuhu Xinzhen Equity Investment Partnership Enterprise (Limited Partnership).Wuhu Token Sciences Co., Ltd. (SZSE:300088) agreed to acquire remaining 43.86% stake in Hybio Pharmaceutical Co., Ltd. (SZSE : 300199) from Anhui Province Railway Development Fund Co.,Ltd. and Wuhu Xinzhen Equity Investment Partnership Enterprise (Limited Partnership) on February 13, 2023. Under the terms, consideration will be paid in cash and Wuhu Token will issue at CNY 5.17 per share. Proceeds from the transaction will be used for projects under construction, and supplement the Hybio Pharmaceutical's working capitals and repay debt, wherein the supplement working capitals and repay debt will be not more than 25% of the acquisition price and not more than 50% of the total proceeds. Transaction is approved by Wuhu Token's board of directors and it subject to approval by shareholders approval. For the period, September 30, 2022, Hybio Pharmaceutical had CNY 2356.2299 million of total assets and CNY 769.1991 million of net assets.お知らせ • Feb 14Wuhu Token Sciences Co., Ltd. announced a financing transactionWuhu Token Sciences Co., Ltd. announced a private placement of common shares on February 13, 2023. The transaction was approved by the board of directors of the company at its 27th Meeting of the Company’s 6th Directorate and subjct to Shareholders, Shenzhen Stock Exchange’s Approval and CSRC. The shares cannot be transferred within 6 months from the issuance closing date.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Zhengdong Liu was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.089 (vs CN¥0.14 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.089 (down from CN¥0.14 in 3Q 2021). Revenue: CN¥1.97b (up 7.5% from 3Q 2021). Net income: CN¥218.5m (down 34% from 3Q 2021). Profit margin: 11% (down from 18% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 4% per year.Reported Earnings • Sep 04Second quarter 2022 earnings released: EPS: CN¥0.075 (vs CN¥0.096 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.075 (down from CN¥0.096 in 2Q 2021). Revenue: CN¥1.50b (down 12% from 2Q 2021). Net income: CN¥183.3m (down 22% from 2Q 2021). Profit margin: 12% (down from 14% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 45%, compared to a 27% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 4% per year.Buying Opportunity • Jul 16Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.3%. The fair value is estimated to be CN¥8.56, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.9% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 61% in 2 years. Earnings is forecast to grow by 89% in the next 2 years.Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.074 (vs CN¥0.094 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.074 (down from CN¥0.094 in 1Q 2021). Revenue: CN¥1.72b (up 11% from 1Q 2021). Net income: CN¥181.4m (down 22% from 1Q 2021). Profit margin: 11% (down from 15% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 42%, compared to a 24% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has remained flat and the company’s share price has also remained flat.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Zhengdong Liu was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Mar 04Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be CN¥11.87, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% per annum over the last 3 years. Earnings per share has grown by 3.1% per annum over the last 3 years.Valuation Update With 7 Day Price Move • Jan 11Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥11.95, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 28x in the Electronic industry in China. Total returns to shareholders of 178% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.09 per share.Valuation Update With 7 Day Price Move • Dec 24Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥13.50, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 31x in the Electronic industry in China. Total returns to shareholders of 242% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.03 per share.Valuation Update With 7 Day Price Move • Oct 29Investor sentiment improved over the past weekAfter last week's 30% share price gain to CN¥10.14, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 26x in the Electronic industry in China. Total returns to shareholders of 113% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥19.49 per share.Reported Earnings • Oct 23Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.13 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: CN¥1.83b (down 2.8% from 3Q 2020). Net income: CN¥332.3m (up 8.8% from 3Q 2020). Profit margin: 18% (up from 16% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 09Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥8.09, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 29x in the Electronic industry in China. Total returns to shareholders of 66% over the past three years.Reported Earnings • Aug 28Second quarter 2021 earnings released: EPS CN¥0.096 (vs CN¥0.12 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.70b (down 3.4% from 2Q 2020). Net income: CN¥235.6m (down 21% from 2Q 2020). Profit margin: 14% (down from 17% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 9% per year.Reported Earnings • Apr 28Full year 2020 earnings released: EPS CN¥0.34 (vs CN¥0.37 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥6.84b (up 14% from FY 2019). Net income: CN¥834.2m (down 1.3% from FY 2019). Profit margin: 12% (down from 14% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Jan 25New 90-day low: CN¥8.24The company is down 22% from its price of CN¥10.54 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.98 per share.Is New 90 Day High Low • Jan 07New 90-day low: CN¥8.53The company is down 19% from its price of CN¥10.50 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.97 per share.Is New 90 Day High Low • Dec 11New 90-day low: CN¥9.58The company is down 13% from its price of CN¥11.00 on 11 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.96 per share.Is New 90 Day High Low • Oct 31New 90-day low: CN¥9.96The company is down 18% from its price of CN¥12.20 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.65 per share.Reported Earnings • Oct 20Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥930.1m, up 14% from the prior year. Total revenue was CN¥6.37b over the last 12 months, down 11% from the prior year. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Wuhu Token Sciences は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測XSEC:300088 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202611,244172-7682N/A12/31/202511,57320435799N/A9/30/202511,379349206939N/A6/30/202511,521390183897N/A3/31/202511,248387-382296N/A12/31/202411,058357-750-8N/A9/30/202411,230229-858-329N/A6/30/202411,133206-1,187-320N/A3/31/202410,020187-876218N/A12/31/20238,889242-638568N/A9/30/20238,105402-582811N/A6/30/20237,149535-351,062N/A3/31/20236,742602341,088N/A1/1/20236,9876803701,314N/A9/30/20227,1146883691,471N/A6/30/20226,9778023531,648N/A3/31/20227,1828542691,464N/A1/1/20227,018904-1871,144N/A9/30/20216,936837-296902N/A6/30/20216,9898103091,248N/A3/31/20217,0498736551,497N/A12/31/20206,8448349181,614N/A9/30/20206,3709301,0351,542N/A6/30/20205,9048965911,186N/A3/31/20205,7158685941,436N/A12/31/20196,024845N/A1,483N/A9/30/20197,129816N/A1,947N/A6/30/20198,469789N/A1,688N/A3/31/20199,543741N/A825N/A12/31/20189,615712N/A753N/A9/30/20189,249695N/A-67N/A6/30/20188,583609N/A411N/A3/31/201812,613686N/A657N/A12/31/201710,884544N/A594N/A9/30/201712,378611N/A626N/A6/30/201712,221547N/A210N/A3/31/20177,705340N/A415N/A12/31/20168,542384N/A260N/A9/30/20165,795297N/A405N/A6/30/20165,201271N/A402N/A3/31/20164,065239N/A376N/A12/31/20153,987238N/A395N/A9/30/20153,664169N/A256N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 300088の予測収益成長が 貯蓄率 ( 2.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 300088の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 300088の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 300088の収益がCN市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 300088の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 300088の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YTech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/09 22:51終値2026/08/07 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Wuhu Token Sciences Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Hongda ZhengHaitong International Research LimitedLiang LiuIndustrial Securities Co. Ltd.Ye LiuJ.P. Morgan5 その他のアナリストを表示
New Risk • Jul 25New major risk - Revenue and earnings growthEarnings have declined by 30% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 30% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.5% net profit margin).
お知らせ • Jun 30Wuhu Token Sciences Co., Ltd. to Report First Half, 2026 Results on Aug 28, 2026Wuhu Token Sciences Co., Ltd. announced that they will report first half, 2026 results on Aug 28, 2026
Declared Dividend • May 30Dividend reduced to CN¥0.05Dividend of CN¥0.05 is 15% lower than last year. Ex-date: 3rd June 2026 Payment date: 3rd June 2026 Dividend yield will be 0.7%, which is lower than the industry average of 1.8%. Sustainability & Growth Dividend is covered by earnings (74% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 66% over the next year, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 30Wuhu Token Sciences Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 3 June 2026Wuhu Token Sciences Co., Ltd. announced 2025 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included) of CNY 0.50000000. Record date: 02 June 2026, Ex-date: 03 June 2026, Payment date: 03 June 2026.
お知らせ • Apr 27Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 18, 2026Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 18, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Wuhu, Anhui China
お知らせ • Mar 31Wuhu Token Sciences Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026Wuhu Token Sciences Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026
お知らせ • Dec 31Wuhu Token Sciences Co., Ltd. to Report Fiscal Year 2025 Results on Apr 27, 2026Wuhu Token Sciences Co., Ltd. announced that they will report fiscal year 2025 results on Apr 27, 2026
お知らせ • Sep 30Wuhu Token Sciences Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Wuhu Token Sciences Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025
お知らせ • Jul 02Wuhu Token Sciences Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025Wuhu Token Sciences Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025
お知らせ • Apr 25Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 15, 2025Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 15, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Wuhu, Anhui China
お知らせ • Mar 31Wuhu Token Sciences Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025Wuhu Token Sciences Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025
お知らせ • Dec 31Wuhu Token Sciences Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025Wuhu Token Sciences Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025
Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: CN¥0.044 (vs CN¥0.035 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.044 (up from CN¥0.035 in 3Q 2023). Revenue: CN¥3.02b (up 3.3% from 3Q 2023). Net income: CN¥108.4m (up 26% from 3Q 2023). Profit margin: 3.6% (up from 2.9% in 3Q 2023). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 33%After last week's 33% share price gain to CN¥6.20, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 21x in the Electronic industry in China. Total loss to shareholders of 13% over the past three years.
お知らせ • Sep 30Wuhu Token Sciences Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024Wuhu Token Sciences Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024
Valuation Update With 7 Day Price Move • Sep 04Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥5.45, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Electronic industry in China. Total loss to shareholders of 30% over the past three years.
Reported Earnings • Aug 29Second quarter 2024 earnings released: EPS: CN¥0.055 (vs CN¥0.047 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.055 (up from CN¥0.047 in 2Q 2023). Revenue: CN¥3.02b (up 59% from 2Q 2023). Net income: CN¥135.1m (up 17% from 2Q 2023). Profit margin: 4.5% (down from 6.1% in 2Q 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 29Wuhu Token Sciences Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024Wuhu Token Sciences Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024
Declared Dividend • Jun 03Dividend reduced to CN¥0.07Dividend of CN¥0.07 is 30% lower than last year. Ex-date: 7th June 2024 Payment date: 7th June 2024 Dividend yield will be 1.4%, which is lower than the industry average of 1.8%. Sustainability & Growth Dividend is not adequately covered by earnings (90.5% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share is expected to grow by 213% over the next 3 years, which should maintain adequate earnings cover for the dividend.
お知らせ • Jun 01Wuhu Token Sciences Co., Ltd. Implements 2023 Final Profit Distribution Plan of A Shares, Payable on 07 June 2024Wuhu Token Sciences Co., Ltd. announced 2023 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 0.70000000. Record date: 06 June 2024, Ex-date: 07 June 2024, Payment date: 07 June 2024.
お知らせ • Apr 28Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 17, 2024Wuhu Token Sciences Co., Ltd., Annual General Meeting, May 17, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Wuhu, Anhui China Agenda: To consider 2023 work report of the board of directors; to consider 2023 annual accounts report; to consider 2023 annual report and its summary; to consider 2023 profit distribution plan; to consider Reappointment of audit firm; to consider 2023 internal control self-evaluation report; to consider 2024 guarantee for subsidiaries and joint stock companies; to consider 2024 provision of guarantee for a company; to consider Special report on the deposit and use of raised funds in 2023; to consider Change of the Company's registered capital and amendments to the Company's articles of association; to consider 2023 work report of the supervisory committee; to consider Amendments to the work system for independent directors; and to consider Formulation of the allowance management measures for independent directors.
お知らせ • Apr 27Wuhu Token Sciences Co., Ltd. Proposes Final Cash Dividend for the Year 2023Wuhu Token Sciences Co., Ltd. proposed final cash dividend per 10 shares (tax included) of CNY 0.70000000 for the year 2023.
Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.043 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.02 (down from CN¥0.043 in 1Q 2023). Revenue: CN¥2.60b (up 77% from 1Q 2023). Net income: CN¥49.5m (down 53% from 1Q 2023). Profit margin: 1.9% (down from 7.1% in 1Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
New Risk • Apr 15New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.0% net profit margin).
お知らせ • Mar 30Wuhu Token Sciences Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Wuhu Token Sciences Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥4.61, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Electronic industry in China. Total loss to shareholders of 38% over the past three years.
お知らせ • Dec 30Wuhu Token Sciences Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Wuhu Token Sciences Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥7.85, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 22x in the Electronic industry in China. Total loss to shareholders of 21% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥3.73 per share.
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.035 (vs CN¥0.089 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.035 (down from CN¥0.089 in 3Q 2022). Revenue: CN¥2.92b (up 49% from 3Q 2022). Net income: CN¥85.9m (down 61% from 3Q 2022). Profit margin: 2.9% (down from 11% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Wuhu Token Sciences Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023Wuhu Token Sciences Co., Ltd. announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023
お知らせ • Sep 14Wuhu Token Sciences Co., Ltd. Announces Executive ElectionsWuhu Token Sciences Co., Ltd. elected Jiang Mingyin and Wu Yunfei as non-independent directors; Luo Kun and Qian Jun as independent directors; and Chang Liping and Wang Wei as non-employee supervisors at the extraordinary general meeting held on September 11, 2023.
New Risk • Sep 03New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 24% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.5% net profit margin).
Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.047 (vs CN¥0.075 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.047 (down from CN¥0.075 in 2Q 2022). Revenue: CN¥1.90b (up 27% from 2Q 2022). Net income: CN¥115.5m (down 37% from 2Q 2022). Profit margin: 6.1% (down from 12% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has fallen by 23% per year, which means it is performing significantly worse than earnings.
お知らせ • May 27Wuhu Token Sciences Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 2, 2023Wuhu Token Sciences Co., Ltd. announced final cash dividend/10 shares (tax included) of CNY 0.99999900 on A shares for the year 2022. Record date is June 1, 2023. Ex-date is June 2, 2023. Payment date is June 2, 2023.
Reported Earnings • Apr 15Full year 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.37 in FY 2021)Full year 2022 results: EPS: CN¥0.28 (down from CN¥0.37 in FY 2021). Revenue: CN¥6.99b (flat on FY 2021). Net income: CN¥679.7m (down 25% from FY 2021). Profit margin: 9.7% (down from 13% in FY 2021). Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 9% per year.
お知らせ • Feb 15Wuhu Token Sciences Co., Ltd. (SZSE:300088) agreed to acquire remaining 43.86% stake in Hybio Pharmaceutical Co., Ltd. (SZSE : 300199) from Anhui Province Railway Development Fund Co.,Ltd. and Wuhu Xinzhen Equity Investment Partnership Enterprise (Limited Partnership).Wuhu Token Sciences Co., Ltd. (SZSE:300088) agreed to acquire remaining 43.86% stake in Hybio Pharmaceutical Co., Ltd. (SZSE : 300199) from Anhui Province Railway Development Fund Co.,Ltd. and Wuhu Xinzhen Equity Investment Partnership Enterprise (Limited Partnership) on February 13, 2023. Under the terms, consideration will be paid in cash and Wuhu Token will issue at CNY 5.17 per share. Proceeds from the transaction will be used for projects under construction, and supplement the Hybio Pharmaceutical's working capitals and repay debt, wherein the supplement working capitals and repay debt will be not more than 25% of the acquisition price and not more than 50% of the total proceeds. Transaction is approved by Wuhu Token's board of directors and it subject to approval by shareholders approval. For the period, September 30, 2022, Hybio Pharmaceutical had CNY 2356.2299 million of total assets and CNY 769.1991 million of net assets.
お知らせ • Feb 14Wuhu Token Sciences Co., Ltd. announced a financing transactionWuhu Token Sciences Co., Ltd. announced a private placement of common shares on February 13, 2023. The transaction was approved by the board of directors of the company at its 27th Meeting of the Company’s 6th Directorate and subjct to Shareholders, Shenzhen Stock Exchange’s Approval and CSRC. The shares cannot be transferred within 6 months from the issuance closing date.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Zhengdong Liu was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.089 (vs CN¥0.14 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.089 (down from CN¥0.14 in 3Q 2021). Revenue: CN¥1.97b (up 7.5% from 3Q 2021). Net income: CN¥218.5m (down 34% from 3Q 2021). Profit margin: 11% (down from 18% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 4% per year.
Reported Earnings • Sep 04Second quarter 2022 earnings released: EPS: CN¥0.075 (vs CN¥0.096 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.075 (down from CN¥0.096 in 2Q 2021). Revenue: CN¥1.50b (down 12% from 2Q 2021). Net income: CN¥183.3m (down 22% from 2Q 2021). Profit margin: 12% (down from 14% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 45%, compared to a 27% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 4% per year.
Buying Opportunity • Jul 16Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.3%. The fair value is estimated to be CN¥8.56, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.9% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 61% in 2 years. Earnings is forecast to grow by 89% in the next 2 years.
Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.074 (vs CN¥0.094 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.074 (down from CN¥0.094 in 1Q 2021). Revenue: CN¥1.72b (up 11% from 1Q 2021). Net income: CN¥181.4m (down 22% from 1Q 2021). Profit margin: 11% (down from 15% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 42%, compared to a 24% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has remained flat and the company’s share price has also remained flat.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Director Zhengdong Liu was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Mar 04Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be CN¥11.87, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% per annum over the last 3 years. Earnings per share has grown by 3.1% per annum over the last 3 years.
Valuation Update With 7 Day Price Move • Jan 11Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥11.95, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 28x in the Electronic industry in China. Total returns to shareholders of 178% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.09 per share.
Valuation Update With 7 Day Price Move • Dec 24Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥13.50, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 31x in the Electronic industry in China. Total returns to shareholders of 242% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.03 per share.
Valuation Update With 7 Day Price Move • Oct 29Investor sentiment improved over the past weekAfter last week's 30% share price gain to CN¥10.14, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 26x in the Electronic industry in China. Total returns to shareholders of 113% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥19.49 per share.
Reported Earnings • Oct 23Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.13 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: CN¥1.83b (down 2.8% from 3Q 2020). Net income: CN¥332.3m (up 8.8% from 3Q 2020). Profit margin: 18% (up from 16% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 09Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥8.09, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 29x in the Electronic industry in China. Total returns to shareholders of 66% over the past three years.
Reported Earnings • Aug 28Second quarter 2021 earnings released: EPS CN¥0.096 (vs CN¥0.12 in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.70b (down 3.4% from 2Q 2020). Net income: CN¥235.6m (down 21% from 2Q 2020). Profit margin: 14% (down from 17% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 9% per year.
Reported Earnings • Apr 28Full year 2020 earnings released: EPS CN¥0.34 (vs CN¥0.37 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥6.84b (up 14% from FY 2019). Net income: CN¥834.2m (down 1.3% from FY 2019). Profit margin: 12% (down from 14% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Jan 25New 90-day low: CN¥8.24The company is down 22% from its price of CN¥10.54 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.98 per share.
Is New 90 Day High Low • Jan 07New 90-day low: CN¥8.53The company is down 19% from its price of CN¥10.50 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.97 per share.
Is New 90 Day High Low • Dec 11New 90-day low: CN¥9.58The company is down 13% from its price of CN¥11.00 on 11 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.96 per share.
Is New 90 Day High Low • Oct 31New 90-day low: CN¥9.96The company is down 18% from its price of CN¥12.20 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.65 per share.
Reported Earnings • Oct 20Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥930.1m, up 14% from the prior year. Total revenue was CN¥6.37b over the last 12 months, down 11% from the prior year.